Search Results

You are looking at 11 - 20 of 2,573 items for :

  • Refine by Access: All x
Clear All
Full access

Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials

Rachel A. Bender Ignacio, Lilie L. Lin, Lakshmi Rajdev, and Elizabeth Chiao

, clinical trials for HIV-associated malignancies (HIVAMs) have also tremendously evolved. Until recently, most cancer-specific treatment trials excluded PLWH. For example, the Friends of Cancer Research HIV Working Group reviewed eligibility criteria from

Full access

Merkel Cell Carcinoma: A Review of Current Advances

Frank Qian Zhan, Vathani Sharon Packianathan, and Nathalie Charlotte Zeitouni

blame . J Invest Dermatol 2007 ; 127 : 2100 – 2103 . 5 Ries LG Melbert D Krapcho M . SEER Cancer Statistics Review, 1975–2005 . Available at: http://seer.cancer.gov/faststats/index.php . Accessed January 23, 2009 . 6 Heath M

Full access

Secondary Neoplasms of the Female Lower Genital Tract After Hematopoietic Cell Transplantation

Howard A. Chang, Saro H. Armenian, and Thanh H. Dellinger

neoplasms is therefore paramount to providing clinicians with early intervention opportunities in this high-risk population. The primary goal of this review is to summarize the current literature describing female lower genital tract neoplasms (dysplasias

Full access

Review of Evidence-Based Support for Pretreatment Imaging in Melanoma

Michael S. Sabel and Sandra L. Wong

Edited by Kerrin G. Robinson

melanoma . Cancer 2005 ; 104 : 570 – 579 . 35 Alvarez S Anorbe E Alcorta P . Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review . AJR Am J Roentgenol 2006 ; 186 : 1342 – 1348

Full access

Impact of NCI-Mandated Scientific Review on Protocol Development and Content

Ning Ning, Jingsheng Yan, Xian-Jin Xie, and David E. Gerber

objectives becoming obsolete. 1 Researchers have voiced concerns about the complexity, length, inconsistencies, excessive demands, and inappropriate conservatism of the review process. 2 – 6 In turn, these steps contribute to delays in and escalating costs

Full access

A Systematic Review of Clinical Decision Support Systems for Clinical Oncology Practice

Pamala A. Pawloski, Gabriel A. Brooks, Matthew E. Nielsen, and Barbara A. Olson-Bullis

systems in oncology practice, we conducted a systematic review of the literature describing real-world implementation of CDS tools for the diagnosis, treatment, and supportive care of patients with cancer. Our objective was to investigate the reported

Full access

Psychostimulants for Cancer-Related Fatigue

William Breitbart and Yesne Alici

relieved fatigue because of chemotherapy-induced anemia. 2 This article is a comprehensive review of psychostimulants, including the traditional psychostimulant medications and the wakefulness-promoting agents used in the management of cancer

Full access

Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review

Ghadeer Olleik, Wassim Kassouf, Armen Aprikian, Jason Hu, Marie Vanhuyse, Fabio Cury, Stuart Peacock, Elin Bonnevier, Ebba Palenius, and Alice Dragomir

review was to assess the clinical utility of newly marketed tests for use in PCa management before initial or repeat biopsy (after negative biopsy), after positive biopsy, and post-prostatectomy. Methods Literature Search The Cochrane, Embase

Full access

BRAF/MEK Dual Inhibitors Therapy in Progressive and Anaplastic Pleomorphic Xanthoastrocytoma: Case Series and Literature Review

Karolina Kata, Juan C. Rodriguez-Quintero, Octavio D. Arevalo, Jackie J. Zhang, Meenakshi Bidwai Bhattacharjee, Cornelius Ware, Antonio Dono, Roy Riascos-Castaneda, Nitin Tandon, Angel Blanco, Yoshua Esquenazi, Leomar Y. Ballester, Mark Amsbaugh, Arthur L. Day, and Jay-Jiguang Zhu

received BRAF and MEK inhibitors concurrently, with distinctive clinical and radiologic outcomes. Methods Medical records from 2010 to 2021 at Memorial Hermann-Texas Medical Center were reviewed after approval of the Committee for the Protection of

Full access

Perioperative Intravesical Chemotherapy in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

Michael R. Abern, Richmond A. Owusu, Mark R. Anderson, Edward N. Rampersaud, and Brant A. Inman

guidelines, the authors sought to reassess the effect of immediate postoperative IVC through performing an updated systematic literature review and meta-analysis. The primary goal is to determine the effect of a single dose of IVC after TUR on NMIBC